This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.
Among Donald Trump’s recent Cabinet nominations is a pick that has alarmed the scientific community: Robert F. Kennedy Jr. for secretary of Health and Human Services. With this choice, Trump has further elevated a conspiracy-minded vaccine skeptic with no medical background, whose views are often not rooted in science. I spoke with my colleague Yasmin Tayag, who covers health, about the damage RFK Jr.’s proposals could do to Americans’ trust in public health—whether he is confirmed or not.
The Elevation of Fringe Beliefs
Lora Kelley: As you’ve written, some of Robert F. Kennedy’s concerns—such as taking on ultra-processed foods and removing toxins from the environment—seem appealing to Americans across the political spectrum, yet his proposed solutions for these problems could pose a danger to Americans. Could you help me understand the gap between some of his seemingly commonsense proposals and the fringe ideologies behind them?
Yasmin Tayag: A lot of Kennedy’s health proposals actually make sense to me: investing in regenerative agriculture, and increasing access to preventive health care, and even removing toxins from the environment are things that sound good to pretty much anyone, regardless of their political party. Kennedy, of course, was until recently a Democrat, and a lot of his environmental and health concerns do reflect the things that the left has historically worried about.
The problem is that when you start looking at how he’s going to execute on these goals, you realize that his track record of proposing solutions is not based in science. We can all agree that it’s a good idea to take toxins out of the environment, but we might not all agree that fluoride is a toxin, as Kennedy seems to suggest. And so you have to ask: How is Kennedy going to make these decisions?
He’s a science skeptic, even though he claims to be a champion of science that lets people make their own decisions about their health. His view is that science as an institution has been so corrupted by corporate influence—he’s always railing against Big Pharma—that anything that comes out of the science institution that we’ve long relied on is bad.
Lora: Even if he doesn’t get confirmed, could Kennedy’s nomination still have an impact on Americans’ trust in public health?
Yasmin: Kennedy being so publicly considered for such a prominent health role has already given legitimacy to the fringe ideas that he’s entertained over the years. He’s said in the past that he believes 5G cellular technology controls our behavior, and he has implied that antidepressants are linked to mass shootings.
For a lot of the public, this might be their first time really having to think about health topics such as fluoridation. If this is not something you think about normally, and all of a sudden, here’s this guy all over the news, talking about his doubts about things that have long been accepted as scientific fact, I think it’s reasonable that people would also start feeling confused. The fact that he is in the public eye and getting a lot of airtime to discuss his skepticism is, at the very least, putting a spotlight on these fringe beliefs and, at worst, making them seem more legitimate than they are.
Lora: Given that bird flu may be a growing threat, how do you anticipate Kennedy might respond to a pandemic as the head of HHS?
Yasmin: It’s unlikely that we would see anything close to a streamlined public-health response, in part because Kennedy is so skeptical of vaccines. That could mean a hesitation to invest in the production of vaccines, or a lack of encouragement for Americans to use them. But I think the broader impact might be if he continues to legitimize the view that vaccines are something to be afraid of. People may refuse to take them.
During the height of the coronavirus pandemic, we had people who believed in science leading HHS, and the response was pretty mediocre: inconsistent communication, inadequate testing, little coordination between state and federal agencies. But at least the interventions made sense from a scientific perspective. With someone who does not believe in basic health principles, we may see an unpredictable response—or even no response.
Lora: What kind of power does this role actually come with?
Yasmin: If Kennedy becomes secretary of HHS, he’s going to have an enormous influence on American public health—he would oversee the Food and Drug Administration, the Centers for Disease Control, the National Institutes of Health, Medicare and Medicaid, and the Administration for Children and Families, among others. And on top of overseeing all of those departments, he would also be the primary adviser to the president on health. So he would be the one telling Donald Trump what health priorities should be. That’s a really scary prospect, because a lot of Kennedy’s perspective on the world doesn’t seem to be rooted in any kind of scientific reality, at least not a mainstream one. He wouldn’t always be able to implement his ideas directly—removing fluoride from water, for example, can happen only at the state and local level—but his endorsement alone could go a long way.
His appointment, though he still needs to be confirmed, seems plausible to me. Kennedy’s audience is a big one—MAGA meets woo-woo, as our colleague Elaine Godfrey has called it—that could further expand support for Trump. But there are still a number of Republican senators he’ll have to win over. Some might take issue with his views on health. Others may feel threatened by his plans to remove corporate influence from the government—Big Pharma, for example, has long provided campaign money to both parties. Kennedy’s plans to overhaul food and pharmaceuticals would also require a ton of regulation, which is exactly what Republicans don’t want. The biggest pitfall for Kennedy would be if his goals run up against Trump’s economic priorities. He was an environmental lawyer, so he’s very anti-oil, whereas Trump is deeply pro-oil. In his past speeches, Trump has said that Kennedy can do whatever he wants, as long as he doesn’t “touch the oil.” I could see Trump or others in the party pushing back on him for that reason.
Related:
Here are four new stories from The Atlantic:
Today’s News
- Speaker Mike Johnson reportedly urged the House Ethics Committee to not publicly release its probe into former Representative Matt Gaetz’s alleged sexual misconduct and illicit drug use.
- Russian President Vladimir Putin and German Chancellor Olaf Scholz had a call about the future of the Ukraine war. It was their first conversation since late 2022.
- Trump selected North Dakota Governor Doug Burgum to be the Interior Department secretary last night; if confirmed by the Senate, Burgum would oversee the country’s public lands.
Dispatches
Explore all of our newsletters here.
Evening Read
The Man Who Will Do Anything for Trump
By Elaina Plott Calabro
Kash Patel was dangerous. On this both Trump appointees and career officials could agree.
A 40-year-old lawyer with little government experience, he joined the administration in 2019 and rose rapidly. Each new title set off new alarms.
When Patel was installed as chief of staff to the acting secretary of defense just after the 2020 election, Mark Milley, the chairman of the Joint Chiefs of Staff, advised him not to break the law in order to keep President Donald Trump in power. “Life looks really shitty from behind bars,” Milley reportedly told Patel. (Patel denies this.)
Read the full article.
More From The Atlantic
Culture Break
Read. “From an early age, I could taste a tour route as soon as I saw it,” Reya Hart writes about growing up with the Grateful Dead. “Tracing the list of cities with my index finger, I knew the roads we’d travel and the meals we’d eat.”
Change your perspective. Apple orchards today can feel like amusement parks, which might turn off purists in search of a peaceful experience. But you should go anyway, Margo Rabb writes.
Play our daily crossword.
Stephanie Bai contributed to this newsletter.
When you buy a book using a link in this newsletter, we receive a commission. Thank you for supporting The Atlantic.
